Eyeleve MGD
- Product NDC
- 72347-010
- 11-digit product format
- 723470010
- Labeler code
- 72347
- Product ID
- 72347-010_39f8fc59-d38b-74d8-e063-6294a90a6445
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Mineral Oil
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Labeler
- Bruder Healthcare
- Application
- M018
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-02-10
- Substance
- LIGHT MINERAL OIL; MINERAL OIL
- Active strength
- 2; 2 mg/.4mL; mg/.4mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Eyeleve MGD
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIGHT MINERAL OIL | 2 mg/.4mL |
| MINERAL OIL | 2 mg/.4mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| N6K5787QVP | Internal UNII lookup |
| T5L8T28FGP | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1236277 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 145b66e2-00e1-410e-8539-e12ffc4f6f82 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 77dc03a4-fbfc-e6a3-fe95-285bbae40d75 | Product name | 2 | 20250814 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72347-010-05 | Eyeleve MGD | 0.4 mL in 1 VIAL, SINGLE-DOSE | EMULSION | 0.4 | 3 | |
| 72347-010-05 | Eyeleve MGD | 5 in 1 BOX | EMULSION | 5 | 3 | |
| 72347-010-30 | Eyeleve MGD | 0.4 mL in 1 VIAL, SINGLE-DOSE | EMULSION | 0.4 | 3 | |
| 72347-010-30 | Eyeleve MGD | 30 in 1 BOX | EMULSION | 30 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | AvPAK | b479d2ae-4b59-916a-e053-2995a90af8ec | 2025-11-11 | Warnings | M018 |
| Sodium Chloride | SODIUM CHLORIDE | Rising Pharma Holdings, Inc. | 42870188-b1d7-4934-a6c0-310530497dac | 2025-11-07 | Warnings | M018 |
| Systane Complete PF | PROPYLENE GLYCOL EMULSION | Alcon Laboratories, Inc. | 798ffdde-1dba-4a3f-a0b6-937f9e958cca | 2025-11-03 | Warnings | M018 |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | M018 |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | M018 |
| Up and Up Dry Eye Relief Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Target Corporation | 3b1834e6-75cf-5380-e063-6294a90ad1d5 | 2025-10-25 | Warnings | M018 |
| Up and Up Dry Eye Relief Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Hanlim | 420274c6-7bf0-0920-e063-6294a90a30be | 2025-10-25 | Warnings | M018 |
| Stye | POLYVINYL ALCOHOL AND POVIDONE | Medtech Products Inc. | 60c11d3d-df20-4d1c-b425-49a84fecea30 | 2025-10-23 | Warnings | M018 |
| TheraTears Lubricant | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 797b0394-2f0f-4733-8d20-ec5bdf3e085d | 2025-10-23 | Warnings | M018 |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | M018 |
| TheraTears Lubricant | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 661d8764-8ae6-4229-9485-867553ee8e16 | 2025-10-23 | Warnings | M018 |
| Refresh Relieva Preservative Free | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 3481f9b3-5a90-40d3-80f8-81f51cc864be | 2025-10-22 | Warnings | M018 |
| Sodium Chloride Normal Salt | SODIUM CHLORIDE | Method Pharmaceuticals | ce84727a-3677-4bf0-e053-2995a90a3ec8 | 2025-10-21 | Warnings | M018 |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | M018 |
| Walgreens Ultra Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4533-2061-e063-6394a90a6e73 | 2025-10-17 | Warnings | M018 |
| Walgreens | SODIUM CHLORIDE | Walgreen Company | 21dfc2cf-65ae-c3fb-e063-6294a90a0a94 | 2025-10-17 | M018 | |
| Xpect Industrial Eye Relief | GLYCERIN, NAPHAZOLINE HCL | Cintas Corporation | a0167d06-7adb-36f4-e053-2a95a90af9ef | 2025-09-30 | Warnings | M018 |
| Xpect Eyewash | EYEWASH | Cintas Corporation | 1d69365d-662b-4248-8fa9-1629451b549a | 2025-09-30 | Warnings | M018 |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | M018 |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | M018 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1236277 | light mineral oil 0.5 % / mineral oil 0.5 % Ophthalmic Solution | PSN | 145b66e2-00e1-410e-8539-e12ffc4f6f82 | 3 |
| 1236277 | mineral oil 5 MG/ML / mineral oil, light 5 MG/ML Ophthalmic Solution | SCD | 145b66e2-00e1-410e-8539-e12ffc4f6f82 | 3 |
| 1236277 | mineral oil 0.5 % / mineral oil light 0.5 % Ophthalmic Drops | SY | 145b66e2-00e1-410e-8539-e12ffc4f6f82 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 72347-010-05 | 72347001005 | 5 VIAL, SINGLE-DOSE in 1 BOX (72347-010-05) / .4 mL in 1 VIAL, SINGLE-DOSE | 2025-02-10 | No | No | Current |
| 72347-010-30 | 72347001030 | 30 VIAL, SINGLE-DOSE in 1 BOX (72347-010-30) / .4 mL in 1 VIAL, SINGLE-DOSE | 2025-02-10 | No | No | Current |